| API | active pharmaceutical agents |
| CARPA | complement activation-related pseudoallergy |
| CMAs | critical material attributes |
| CPPs | critical process parameters |
| CQAs | critical quality attributes |
| D[3,2] | surface-weighted mean |
| D[4,2] | volume-weighted mean |
| DoE | design of experiments |
| DS | design space |
| EE | encapsulation efficiency |
| GUV | giant unilamellar vesicle |
| ICH | International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use |
| IV | intravenous |
| ISO | International Organisation for Standardisation |
| LUV | large unilamellar vesicle |
| MUV | medium-sized unilamellar vesicle |
| MVL | multivesicular liposomes |
| PdI | polydispersity index |
| PE | phosphatidylethanolamine |
| PEG | polyethylene glycol |
| QbD | quality by design |
| QTPP | quality target product profile |
| RA | risk assessment |
| RES | reticuloendothelial system |
| SSA | specific surface area |
| SUV | small unilamellar vesicle |
| Tm | phase transition temperature |